HIV Clinical Trials
Recruiting hiv studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat hiv. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting hiv studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting hiv trials
Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults
Intervention to Reduce Implicit Bias in Pharmacies
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida
PrEPwise Pilot Among Black Women in Eastern Virginia
HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria
Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care
Yuva Sath: A Peer-led Behavioral Intervention to Support Substance Use Treatment and HIV Prevention Among Young People Who Inject Drugs in India
A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community Clinics
Decision Support Tool to Integrate PrEP Into Emergency Departments
Improving HIV Prevention and Substance Use Post-Sexual Assault Services
Optimizing Implementation of Long Acting Injectable PrEP
Implementation of PrEP Care Among Women in Family Planning Clinics
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
Theoretically Informed Behavioral Intervention
Peer-led Community-based PrEP Delivery Among Youth in Brazil
Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)
Digital Intervention Delivered Via Street Medicine to Increase HIV and Substance Use Care Among Survivors of Sex Trafficking
TelePharm PrEP/PEP
INTEGRATE-RX: Integrating Clinical Pharmacists in HIV Care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Developing an HIV Disclosure Intervention for Men in Uganda
Confidential Care and Adolescent HIV Testing
Development of a Multilevel HIV Prevention Intervention for the Emergency Department
Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
HIV Testing in Community Health Center Dental Clinics
Baricitinib Curative Repression of HIV-1
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania
Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial
Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults
Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF
Evaluating the Healthy Families PrEP Program for Women at Risk for HIV
Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Alabama
Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0)
Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults
Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta
PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants.
Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM
Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System
Improving Clinic Delivery of HIV-related Anal Health Services
Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV
PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men
Combining Social Network Strategies and Routine Substance Use Screening
BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission
Robotic Bronchoscopy With CBCT Image Fusion for Pulmonary Nodule Diagnosis in People Living With HIV
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
Developing a Chatbot to Promote HIV Testing
Leveraging Chatbot to Improve PrEP in the Southern United States
HIV clinical trials — common questions
Are hiv clinical trials free to join?
Yes. Participating in a hiv clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a hiv clinical trial?
Each hiv study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a hiv trial near me?
Use the location controls above. We'll show recruiting hiv trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many hiv trials are recruiting right now?
We're currently tracking roughly 244 recruiting hiv trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.